These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30320573)

  • 41. Predictors That a Diagnosis of Mild Cognitive Impairment Will Remain Stable 3 Years Later.
    Clem MA; Holliday RP; Pandya S; Hynan LS; Lacritz LH; Woon FL
    Cogn Behav Neurol; 2017 Mar; 30(1):8-15. PubMed ID: 28323681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.
    Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L
    Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and correlates of dementia and mild cognitive impairment classified with different versions of the modified Telephone Interview for Cognitive Status (TICS-m).
    Lindgren N; Rinne JO; Palviainen T; Kaprio J; Vuoksimaa E
    Int J Geriatr Psychiatry; 2019 Dec; 34(12):1883-1891. PubMed ID: 31469194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mild cognitive impairment and dementia in primary care: the value of medical history.
    Olazarán J; Torrero P; Cruz I; Aparicio E; Sanz A; Mula N; Marzana G; Cabezón D; Begué C
    Fam Pract; 2011 Aug; 28(4):385-92. PubMed ID: 21402661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for transitions from normal to mild cognitive impairment and dementia.
    Kryscio RJ; Schmitt FA; Salazar JC; Mendiondo MS; Markesbery WR
    Neurology; 2006 Mar; 66(6):828-32. PubMed ID: 16567698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.
    Monsell SE; Liu D; Weintraub S; Kukull WA
    Int Psychogeriatr; 2012 Oct; 24(10):1553-60. PubMed ID: 22717299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Annual rate and predictors of conversion to dementia in subjects presenting mild cognitive impairment criteria defined according to a population-based study.
    Amieva H; Letenneur L; Dartigues JF; Rouch-Leroyer I; Sourgen C; D'Alchée-Birée F; Dib M; Barberger-Gateau P; Orgogozo JM; Fabrigoule C
    Dement Geriatr Cogn Disord; 2004; 18(1):87-93. PubMed ID: 15087583
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toward Prevention of Mild Cognitive Impairment in Older Adults With Depression: An Observational Study of Potentially Modifiable Risk Factors.
    Gallagher D; Kiss A; Lanctot KL; Herrmann N
    J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pre-MCI and MCI: neuropsychological, clinical, and imaging features and progression rates.
    Duara R; Loewenstein DA; Greig MT; Potter E; Barker W; Raj A; Schinka J; Borenstein A; Schoenberg M; Wu Y; Banko J; Potter H
    Am J Geriatr Psychiatry; 2011 Nov; 19(11):951-60. PubMed ID: 21422909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of Mexican Americans with mild cognitive impairment and Alzheimer's disease.
    O'Bryant SE; Johnson L; Balldin V; Edwards M; Barber R; Williams B; Devous M; Cushings B; Knebl J; Hall J
    J Alzheimers Dis; 2013; 33(2):373-9. PubMed ID: 22976076
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estimating Bidirectional Transitions and Identifying Predictors of Mild Cognitive Impairment.
    Qin Y; Han H; Li Y; Cui J; Jia H; Ge X; Ma Y; Bai W; Zhang R; Chen D; Yi F; Yu H
    Neurology; 2023 Jan; 100(3):e297-e307. PubMed ID: 36220593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parkinson's and Alzheimer's diseases: Focus on mild cognitive impairment.
    Korczyn AD
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S159-61. PubMed ID: 26516060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Effect of the APOE ε2ε4 Genotype on the Development of Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI) in Non-Latino Whites.
    Ren D; Lopez OL; Lingler JH; Conley Y
    J Am Geriatr Soc; 2020 May; 68(5):1044-1049. PubMed ID: 32017008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical Conversion or Reversion of Mild Cognitive Impairment in Community versus Hospital Based Studies: GDEMCIS (Gwangju Dementia and Mild Cognitive Impairment Study) and CREDOS (Clinical Research Center for Dementia of South Korea).
    Roh HW; Hong CH; Lee Y; Lee KS; Chang KJ; Kang DR; Lee JD; Choi SH; Kim SY; Na DL; Seo SW; Kim DK; Back JH; Chung YK; Lim KY; Noh JS; Son SJ
    J Alzheimers Dis; 2016 May; 53(2):463-73. PubMed ID: 27163831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of the Spanish version of the Everyday Cognition scale in the diagnosis of mild cognitive impairment and mild dementia in an older cohort from the Argentina-ADNI.
    Russo MJ; Cohen G; Chrem Mendez P; Campos J; Martín ME; Clarens MF; Tapajoz F; Harris P; Sevlever G; Allegri RF
    Aging Clin Exp Res; 2018 Oct; 30(10):1167-1176. PubMed ID: 29380265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study.
    Udeh-Momoh C; Price G; Ropacki MT; Ketter N; Andrews T; Arrighi HM; Brashear HR; Robb C; Bassil DT; Cohn M; Curry LK; Su B; Perera D; Giannakopoulou P; Car J; Ward HA; Perneczky R; Novak G; Middleton L
    J Prev Alzheimers Dis; 2019; 6(4):256-266. PubMed ID: 31686098
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Smailagic N; Vacante M; Hyde C; Martin S; Ukoumunne O; Sachpekidis C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010632. PubMed ID: 25629415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.